Zydus Lifesciences to Acquire Majority Stake in Amplitude Surgical

Zydus Lifesciences is set to acquire a majority stake in France-based Amplitude Surgical. The deal, valued at 256.8 million euros, involves the acquisition of 85.6% of the company's share capital. Amplitude Surgical is a leading European MedTech company specializing in lower-limb orthopedic technologies.

Zydus Lifesciences announced on Tuesday its plan to take over a majority stake in the French firm Amplitude Surgical for 256.8 million euros. The Ahmedabad-based company will acquire 85.6% of Amplitude's share capital.

Amplitude, a notable name in the European medical technology sector, specializes in advanced lower-limb orthopedic solutions. It reported consolidated sales of 106.0 million euros and an EBITDA of 27.1 million euros for the year ending June 30, 2024.

Zydus Lifesciences' MD, Sharvil Patel, expressed confidence that this acquisition aligns with their strategic expansion in the MedTech arena, capitalizing on the domain's specialized product offerings.

(With inputs from agencies.)